MedTrace Logo

Enhanced Genetic Awareness and Genetic Evaluation for Men Through Technology, ENGAGEMENT Study

NCT04789018 · Status: ACTIVE_NOT_RECRUITING · Type: OBSERVATIONAL · Enrollment: 118

Last updated 2025-10-10

No results posted yet for this study

Summary

This study assesses perceived usefulness of a web-based virtual prostate cancer genetics board for providers across academic, community, and veteran affairs settings to discuss prostate cancer genetics cases, precision treatment, and screening recommendation. Information gained from interviews and surveys of participants taking part in the virtual genetics board may lend insights into perceived usefulness, perceived ease of use, acceptability, self-efficacy, genetics knowledge, and barriers/facilitators to implementation to refine the process.

Conditions

  • Prostate Carcinoma

Interventions

OTHER

Educational Intervention

Attend virtual genetics board

OTHER

Survey Administration

Complete survey

OTHER

Interview

Complete interview

Sponsors & Collaborators

  • Thomas Jefferson University

    lead OTHER

Principal Investigators

  • Amy Leader, DrPH, MPH · Thomas Jefferson University

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-01-21
Primary Completion
2026-06-24
Completion
2026-06-24

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04789018 on ClinicalTrials.gov